Patent ID: 6716446
Filing Date: 2004-04-06
Classification: A61K,A61P,Y10S

Abstract:
A process for reducing an activity level of endometriosis implants or peritoneal leukocytes in a woman, having a peritoneal cavity and a uterine cavity, to reduce dysmenorrhoea in the woman relative to the woman's present dysmenorrhoea, comprising:mixing a compound which acts as a local anesthetic with a physiological salt to form a pharmaceutical composition comprising a pharmaceutically effective concentration of the local anesthetic with a pharmaceutically acceptable excipient; placing the pharmaceutical composition into a catheter; administering the pharmaceutical composition into the uterine cavity of the woman with the catheter to fill the uterine cavity with the pharmaceutical composition and permitting the pharmaceutical composition to overflow through fallopian tubes and into the peritoneal cavity; and depositing the pharmaceutical composition, flowing in the fallopian tubes, at a bottom of the peritoneal cavity in an amount of the pharmaceutical composition sufficient for reducing an activity level of the endometriosis implants or peritoneal leukocytes to reduce the woman's dysmenorrhoea.